NEW YORK, March 19, 2015 — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (AVXL), a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’s and other central nervous system
NEW YORK, March 17, 2015 — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (AVXL), a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’s and other central nervous system
Los Angeles, C.A. – March 16, 2015 – Since its founding in 2002, Athgo International (http://bit.ly/1x6c0n3) has been a major international force for change. Athgo offers a unique array of
NEW YORK, March 12, 2015 — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (AVXL), a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’s disease, other central nervous system
NEW YORK, March 10, 2015 — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (AVXL) a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’s disease, other central nervous system (CNS)
March 5, 2015 – Boca Raton, Florida — Many regard gold and silver as strong investment options to protect against inflation. Seven Star Enterprises International works to advise investors about
